Soleno Therapeutics(SLNO)
REDWOOD CITY, CA
BiotechnologyFocus: Small Molecule, Carbon Monoxide Monitoring Device
Soleno Therapeutics is a life sciences company focused on Small Molecule, Carbon Monoxide Monitoring Device.
Metabolic Diseases
Funding Stage
PUBLIC
Total Funding
$NaNB
Open Jobs
0
Products & Portfolio (1)
Pipeline & Clinical Trials
Interview
Prader-Willi SyndromeClinical Trials (1)
NCT04102839PWS Outcomes Assessment Study
N/AVYKAT XR
Prader-Willi SyndromeClinical Trials (1)
NCT07450664Observational Study of VYKAT™ XR in Patients With Prader-Willi Syndrome
N/APhase 2
Clinical Trials (1)
NCT05532020An Open-Label Study of Diazoxide Choline in Patients With Genetic Obesities
Phase 2Phase 3
Clinical Trials (1)
NCT05701774Open-Label Extension Study of DCCR in Patients With Prader-Willi Syndrome
Phase 3Phase 3
Clinical Trials (1)
NCT03714373Open-Label Extension Study of DCCR in PWS Followed by Double-Blind, Placebo-Controlled, Randomized Withdrawal Period
Phase 3Phase 3
Clinical Trials (1)
NCT03440814A Study of Diazoxide Choline in Patients With Prader-Willi Syndrome
Phase 3Phase 3
Clinical Trials (1)
NCT04086810An Open-Label Study of DCCR Tablet in Patients With PWS
Phase 3Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Portfolio: 1 approved product, 7 clinical trials
SEC Filings: 2 available
Portfolio Health
Launch1 (100%)
1 total products
Hiring Trend
Stable
0
Open Roles
+0
Added
-0
Filled/Removed
Based on last 4 crawl cycles